申请人:St. Laurent Joseph P.
公开号:US20100240756A1
公开(公告)日:2010-09-23
The present invention is directed to a compound of 2-N halo-4-methylsulfonyl-butyric acid, such as 2-N chloro-4-methylsulfonyl-butyric acid, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed to a pharmaceutical composition comprises the compound and a pharmaceutically acceptable carrier. The present invention is further directed to a method for treating inflammation or inflammatory-related disorders, bacterial infection, pain, or skin conditions, by administering 2-N halo-4-methylsulfonyl-butyric acid to a subject in need thereof.
本发明涉及一种2-N卤代-4-甲基磺酰基丁酸化合物,例如2-N氯代-4-甲基磺酰基丁酸或其药学上可接受的盐或溶剂。本发明还涉及一种制药组合物,包括该化合物和药学上可接受的载体。本发明还涉及一种方法,通过向需要的受体给予2-N卤代-4-甲基磺酰基丁酸来治疗炎症或炎症相关疾病、细菌感染、疼痛或皮肤病。